Systems for cardiac ablation and associated methods

Patent metadata

Field	Value
Publication number	US-12575880-B2
Application number	US-202218061378-A
Country	US
Kind code	B2
Filing date	Dec 2, 2022
Priority date	Jan 24, 2020
Publication date	Mar 17, 2026
Grant date	Mar 17, 2026

Abstract

Devices, systems, and methods for treating cardiac arrhythmia are disclosed herein. In some embodiments, devices, systems, and methods disclosed herein deliver interrogating energy to tissue at a position on a wall of an anatomical structure of a patient. If the devices, systems, and methods disclosed herein detect a change in electrical activity of the anatomical structure in response to the interrogating energy, the devices, systems, and methods disclosed herein can apply irreversible therapy to the tissue. In some embodiments, the change in electrical activity corresponds to slowing or termination of a detected arrhythmia.

First claim

We claim:

1 . A method, comprising:
delivering first energy to first target tissue of an anatomical structure of a patient via an electrode carried by a catheter; measuring electrical activity of the anatomical structure after delivering the first energy; analyzing the measured electrical activity to detect a change in an arrhythmia caused by the first energy; displaying a first therapy annotation in a three-dimensional model of the anatomical structure at a location in the model corresponding to a location of a tip section of the catheter in the anatomical structure when the first energy was delivered to the first target tissue, wherein the first therapy annotation includes a first set of visual properties, and wherein one or more visual properties of the first set are updated dynamically as a function of time to indicate whether the first energy delivered to the first target tissue slowed or terminated the arrhythmia based on the detected change in the arrhythmia and to indicate a predicted extent of recovery of electrical activity of the first target tissue at a given time after delivering the first energy; delivering second energy to second target tissue of the anatomical structure via the electrode of the catheter, wherein the second target tissue at least partially overlaps with the first target tissue; and after delivering the second energy, displaying a second therapy annotation in the three-dimensional model of the anatomical structure corresponding to delivery of the second energy to the second target tissue.

2 . The method of claim 1 wherein the first set of visual properties includes a color and/or a pattern of the first therapy annotation, and wherein the one or more visual properties include a density, an intensity, a shade, and/or an opacity of the color and/or the pattern.

3 . The method of claim 1 wherein the one or more visual properties include a color and/or a pattern of the first therapy annotation.

4 . The method of claim 3 wherein the color and/or the pattern of the first therapy annotation include(s):
a first color and/or a first pattern when the first energy delivered to the first target tissue did not slow or terminate the arrhythmia; and
a second color and/or a second pattern when the first energy delivered to the first target tissue slowed or terminated the arrhythmia,
wherein the second color and/or the second pattern is/are different from the first color and/or the first pattern, respectively.

5 . The method of claim 3 wherein the color and/or the pattern of the first therapy annotation include(s):
a first color and/or a first pattern when the first energy delivered to the first target tissue slows a cycle time of the arrhythmia by less than 10 ms; and
a second color and/or a second pattern when the first energy delivered to the first target tissue slows the cycle time of the arrhythmia by greater than or equal to 10 ms,
wherein the second color and/or the second pattern is/are different from the first color and/or the first pattern, respectively.

6 . The method of claim 5 wherein the color and/or the pattern of the first therapy annotation include(s) a third color and/or a third pattern when the first energy delivered to the first target tissue terminates the arrhythmia, and wherein the third color and/or the third pattern is/are different from the first and second colors and/or the first and second patterns, respectively.

7 . The method of claim 1 wherein the first set of visual properties includes a size of the first therapy annotation indicative of an extent of contact between the tip section of the catheter and the first target tissue when the first energy was delivered to the first target tissue.

8 . The method of claim 1 wherein the first set of visual properties includes a shape of the first therapy annotation indicative of a type of energy of the first energy delivered to the first target tissue.

9 . The method of claim 8 wherein the shape of the first therapy annotation includes:
a first shape when the first energy includes stunning energy; and
a second shape when the first energy includes ablative energy.

10 . The method of claim 1 wherein the first set of visual properties provides an indication of an orientation of the tip section of the catheter relative to the first target tissue when the first energy was delivered to the first target tissue.

11 . The method of claim 1 wherein the first set of visual properties provides an indication of which portion of the tip section was contacting the first target tissue when the first energy was delivered to the first target tissue.

12 . The method of claim 1 wherein the first set of visual properties provides an indication of characteristics of the first energy delivered to the first target tissue, wherein the characteristics include a voltage level of the first energy delivered to the first target tissue, a current level of the first energy delivered to the first target tissue, a total time the first energy was applied to the first target tissue, or a combination thereof.

13 . The method of claim 1 wherein the first set of visual properties provides an indication of a type of energy of the first energy delivered to the first target tissue.

14 . The method of claim 1 wherein displaying the first therapy annotation includes generating and/or displaying the first therapy annotation in real time as the first energy is delivered to the first target tissue.

15 . The method of claim 1 wherein delivering the first energy comprises delivering stunning energy to the first target tissue.

16 . The method of claim 1 wherein delivering the first energy comprises delivering ablative energy to the first target tissue.

17 . The method of claim 1 wherein delivering the second energy comprises delivering ablative energy to the second target tissue.

18 . The method of claim 1 wherein delivering the second energy comprises delivering stunning energy to the second target tissue.

19 . The method of claim 1 , further comprising detecting, prior to delivering the first energy to the first target tissue, the arrhythmia based at least in part on electrical signals measured using the tip section of the catheter, a multipolar catheter separate from the catheter, or a combination thereof.

20 . The method of claim 1 wherein displaying the second therapy annotation includes displaying the second therapy annotation with a second set of visual properties that provides an indication of whether delivering the second energy to the second target tissue reinduced the arrhythmia.

21 . The method of claim 1 wherein displaying the second therapy annotation includes displaying the second therapy annotation at a location in the model corresponding to a location of the tip section of the catheter in the anatomical structure when the second energy was delivered to the second target tissue.

22 . A method comprising:
delivering reversible energy to target tissue of an anatomical structure of a patient via an electrode carried by a catheter, wherein the reversible energy temporarily alters electrical activity of the target tissue; displaying a therapy annotation in a three-dimensional model of the anatomical structure at a location in the model corresponding to a location of a tip section of the catheter in the anatomical structure when the reversible energy was delivered to the target tissue, wherein the therapy annotation includes one or more visual properties; and ch

Assignees

• Affera Inc

Inventors

• Harlev Doron
• Hultz Paul B

Classifications

• A61B2018/0212

  using an instrument inserted into a body lumen, e.g. catheter · CPC title

• A61B2018/00839

  Bioelectrical parameters, e.g. ECG, EEG · CPC title

• A61B2018/00577

  Ablation · CPC title

• A61B2018/00351

  Heart · CPC title

• A61B2018/0022

  Balloons · CPC title